26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Figueiredo F, Sárkány Z, Silva A, Vilasboas-Campos D, Maciel P, Teixeira-Castro A, Martins PM, Macedo-Ribeiro S. Drug repurposing of dopaminergic drugs to inhibit ataxin-3 aggregation. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 165: 115258. PMID 37549460 DOI: 10.1016/j.biopha.2023.115258  0.581
2023 Cunha-Garcia D, Monteiro-Fernandes D, Correia JS, Neves-Carvalho A, Vilaça-Ferreira AC, Guerra-Gomes S, Viana JF, Oliveira JF, Teixeira-Castro A, Maciel P, Duarte-Silva S. Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IPR2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3. International Journal of Molecular Sciences. 24. PMID 37445783 DOI: 10.3390/ijms241310606  0.62
2023 Teixeira-Castro A, Sousa JC, Vieira C, Pereira-Sousa J, Vilasboas-Campos D, Marques F, Pinto-do-Ó P, Maciel P. Learning the Biochemical Basis of Axonal Guidance: Using as a Model. Biomedicines. 11. PMID 37371826 DOI: 10.3390/biomedicines11061731  0.528
2022 Campos AB, Duarte-Silva S, Fernandes B, Coimbra B, Campos J, Monteiro-Fernandes D, Teixeira-Castro A, Ambrósio AF, Maciel P. Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado-Joseph Disease. Cells. 11. PMID 35805106 DOI: 10.3390/cells11132022  0.528
2022 Jalles A, Vieira C, Pereira-Sousa J, Vilasboas-Campos D, Mota AF, Vasconcelos S, Ferreira-Lomba B, Costa MD, Da Silva JD, Maciel P, Teixeira-Castro A. Aripiprazole Offsets Mutant ATXN3-Induced Motor Dysfunction by Targeting Dopamine D and Serotonin 1A and 2A Receptors in . Biomedicines. 10. PMID 35203579 DOI: 10.3390/biomedicines10020370  0.584
2022 Campos AB, Duarte-Silva S, Fernandes B, das Neves SP, Marques F, Teixeira-Castro A, Neves-Carvalho A, Monteiro-Fernandes D, Portugal CC, Socodato R, Summavielle T, Ambrósio AF, Relvas JB, Maciel P. Profiling Microglia in a Mouse Model of Machado-Joseph Disease. Biomedicines. 10. PMID 35203447 DOI: 10.3390/biomedicines10020237  0.528
2021 Correia JS, Neves-Carvalho A, Mendes-Pinheiro B, Pires J, Teixeira FG, Lima R, Monteiro S, Silva NA, Soares-Cunha C, Serra SC, Duarte-Silva S, Teixeira-Castro A, Salgado AJ, Maciel P. Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3. Biomedicines. 9. PMID 34944570 DOI: 10.3390/biomedicines9121754  0.591
2021 Da Silva JD, Costa MD, Almeida B, Lopes F, Maciel P, Teixeira-Castro A. Case Report: A Novel Mutation Causes Global Developmental Delay With Intellectual Disability and Behavioral Disorders. Frontiers in Neurology. 12: 735549. PMID 34646230 DOI: 10.3389/fneur.2021.735549  0.579
2021 Pereira-Sousa J, Ferreira-Lomba B, Bellver-Sanchis A, Vilasboas-Campos D, Fernandes JH, Costa MD, Varney MA, Newman-Tancredi A, Maciel P, Teixeira-Castro A. Identification of the 5-HT serotonin receptor as a novel therapeutic target in a C. elegans model of Machado-Joseph disease. Neurobiology of Disease. 152: 105278. PMID 33516872 DOI: 10.1016/j.nbd.2021.105278  0.528
2020 Vilasboas-Campos D, Costa MD, Teixeira-Castro A, Rios R, Silva FG, Aierken A, Zhang X, Bessa C, Dias ACP, Maciel P. Data on the effects of spp. and spp. plant extracts in models of genetically determined neurodegenerative diseases. Data in Brief. 33: 106598. PMID 33318982 DOI: 10.1016/j.dib.2020.106598  0.59
2020 Vilasboas-Campos D, Costa MD, Teixeira-Castro A, Rios R, Silva FG, Bessa C, Dias ACP, Maciel P. Neurotherapeutic effect of Hyptis spp. leaf extracts in Caenorhabditis elegans models of tauopathy and polyglutamine disease: Role of the glutathione redox cycle. Free Radical Biology & Medicine. PMID 33096249 DOI: 10.1016/j.freeradbiomed.2020.10.018  0.62
2020 Neves-Carvalho A, Duarte-Silva S, Teixeira-Castro A, Maciel P. Polyglutamine spinocerebellar ataxias: emerging therapeutic targets. Expert Opinion On Therapeutic Targets. 24: 1099-1119. PMID 32962458 DOI: 10.1080/14728222.2020.1827394  0.528
2019 Da Silva JD, Oliveira S, Pereira-Sousa J, Teixeira-Castro A, Costa MD, Maciel P. Loss of egli-1, the Caenorhabditis elegans Orthologue of a Downstream Target of SMN, Leads to Abnormalities in Sensorimotor Integration. Molecular Neurobiology. PMID 31797327 DOI: 10.1007/s12035-019-01833-0  0.528
2019 Da Silva JD, Teixeira-Castro A, Maciel P. From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 31691128 DOI: 10.1007/s13311-019-00798-1  0.528
2019 Pohl F, Teixeira-Castro A, Costa MD, Lindsay V, Fiúza-Fernandes J, Goua M, Bermano G, Russell W, Maciel P, Kong Thoo Lin P. GST-4-Dependent Suppression of Neurodegeneration in Models of Parkinson's and Machado-Joseph Disease by Rapeseed Pomace Extract Supplementation. Frontiers in Neuroscience. 13: 1091. PMID 31680826 DOI: 10.3389/fnins.2019.01091  0.599
2018 Ashraf NS, Duarte-Silva S, Shaw ED, Maciel P, Paulson HL, Teixeira-Castro A, Costa MDC. Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease. Molecular Neurobiology. PMID 30187384 DOI: 10.1007/s12035-018-1331-2  0.625
2018 Esteves S, Oliveira S, Duarte-Silva S, Cunha-Garcia D, Teixeira-Castro A, Maciel P. Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph Disease. Molecular Neurobiology. PMID 30173407 DOI: 10.1007/s12035-018-1332-1  0.62
2018 Duarte-Silva S, Neves-Carvalho A, Soares-Cunha C, Silva JM, Teixeira-Castro A, Vieira R, Silva-Fernandes A, Maciel P. Neuroprotective effects of creatine in the CMVMJD135 mouse model of spinocerebellar ataxia type 3. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29570846 DOI: 10.1002/mds.27292  0.611
2015 Esteves S, Duarte-Silva S, Naia L, Neves-Carvalho A, Teixeira-Castro A, Rego AC, Silva-Fernandes A, Maciel P. Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease. Plos One. 10: e0141610. PMID 26505994 DOI: 10.1371/journal.pone.0141610  0.624
2015 Teixeira-Castro A, Jalles A, Esteves S, Kang S, da Silva Santos L, Silva-Fernandes A, Neto MF, Brielmann RM, Bessa C, Duarte-Silva S, Miranda A, Oliveira S, Neves-Carvalho A, Bessa J, Summavielle T, et al. Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease. Brain : a Journal of Neurology. PMID 26373603 DOI: 10.1093/Brain/Awv262  0.633
2014 Duarte-Silva S, Neves-Carvalho A, Soares-Cunha C, Teixeira-Castro A, Oliveira P, Silva-Fernandes A, Maciel P. Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease. Cerebellum (London, England). 13: 713-27. PMID 25112410 DOI: 10.1007/s12311-014-0589-9  0.594
2014 Silva-Fernandes A, Duarte-Silva S, Neves-Carvalho A, Amorim M, Soares-Cunha C, Oliveira P, Thirstrup K, Teixeira-Castro A, Maciel P. Chronic treatment with 17-DMAG improves balance and coordination in a new mouse model of Machado-Joseph disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 433-49. PMID 24477711 DOI: 10.1007/s13311-013-0255-9  0.592
2011 Teixeira-Castro A, Ailion M, Jalles A, Brignull HR, Vilaça JL, Dias N, Rodrigues P, Oliveira JF, Neves-Carvalho A, Morimoto RI, Maciel P. Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways. Human Molecular Genetics. 20: 2996-3009. PMID 21546381 DOI: 10.1093/Hmg/Ddr203  0.575
2011 Rodrigues AJ, Neves-Carvalho A, Teixeira-Castro A, Rokka A, Corthals G, Logarinho E, Maciel P. Absence of ataxin-3 leads to enhanced stress response in C. elegans. Plos One. 6: e18512. PMID 21526185 DOI: 10.1371/journal.pone.0018512  0.546
2007 Ferro A, Carvalho AL, Teixeira-Castro A, Almeida C, Tomé RJ, Cortes L, Rodrigues AJ, Logarinho E, Sequeiros J, Macedo-Ribeiro S, Maciel P. NEDD8: a new ataxin-3 interactor. Biochimica Et Biophysica Acta. 1773: 1619-27. PMID 17935801 DOI: 10.1016/j.bbamcr.2007.07.012  0.663
2006 Costa MDC, Teixeira-Castro A, Constante M, Magalhães M, Magalhães P, Cerqueira J, Vale J, Passão V, Barbosa C, Robalo C, Coutinho P, Barros J, Santos MM, Sequeiros J, Maciel P. Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. Journal of Human Genetics. 51: 645-651. PMID 16858508 DOI: 10.1007/s10038-006-0001-9  0.662
Show low-probability matches.